🇺🇸 FDA
Pipeline program

Ginkgo Diterpene Lactone Meglumine Injection

jm137312ccx

Phase 3 small_molecule active

Quick answer

Ginkgo Diterpene Lactone Meglumine Injection for Ischemic Stroke is a Phase 3 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).

Program details

Company
INTEGRATED BIOPHARMA INC
Indication
Ischemic Stroke
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials